University of Pennsylvania, Philadelphia, PA 19104-4215, USA.
Curr Drug Metab. 2012 Jan;13(1):70-81. doi: 10.2174/138920012798356916.
Endothelium lining the luminal surface of blood vessels is the key target and barrier for vascular drug delivery. Nanocarriers coated with antibodies or affinity peptides that bind specifically to endothelial surface determinants provide targeted delivery of therapeutic cargoes to these cells. Endothelial targeting consists of several phases including circulation in the bloodstream, anchoring on the endothelial surface and, in some cases, intracellular uptake and trafficking of the internalized materials. Dynamic parameters of the vasculature including the blood hydrodynamics as well as surface density, accessibility, membrane mobility and clustering of target determinants modulate these phases of the targeting, especially anchoring to endothelium. Further, such controlled parameters of design of drug nanocarriers such as affinity, surface density and epitope specificity of targeting antibodies, carrier size and shape also modulate endothelial targeting and resultant sub-cellular addressing. This article reviews experimental and computational approaches for analysis of factors modulating targeting nanocarriers to the endothelial cells.
血管腔内皮细胞是血管内药物输送的关键靶点和屏障。通过将与内皮表面决定因素特异性结合的抗体或亲和肽包被纳米载体,可以将治疗性货物靶向递送到这些细胞。内皮靶向作用包括几个阶段,包括在血液中循环、在内皮表面锚定,以及在某些情况下,内化物质的细胞内摄取和运输。血管的动态参数,包括血液动力学以及表面密度、可及性、膜流动性和靶决定因素的聚集,调节靶向作用的这些阶段,特别是与内皮的锚定。此外,药物纳米载体的设计的受控参数,如靶向抗体的亲和力、表面密度和表位特异性、载体大小和形状,也调节内皮靶向作用和随后的细胞内寻址。本文综述了用于分析调节靶向纳米载体到内皮细胞的因素的实验和计算方法。